NIVI Development will facilitate the translational efforts of NIVI by providing industry-level expertise in vaccine development and conducting the early clinical testing of our vaccine candidates.
Bridging research, translational sciences, and development
NIVI Development will catalyse progress towards achieving the NIVI mission by enabling access to cutting-edge technologies and data-driven approaches to design, test, and optimise novel vaccine candidates. NIVI Development provides capabilities and expertise – either directly, or via external strategic partnerships – to bridge exploratory research and clinical (Phase 1 & 2, including CHIM) translational development.
Nick Jackson
CEO & Executive Director
Biography
Niels Thulstrup
Chief Business Officer
Biography
Mike Whelan
Head of PMO
Biography
Jane Ellen Elvekjaer
Personal Assistant to CEO
Biography
We are a part of NIVI
– the Novo Nordisk Foundation Initiative for Vaccines and Immunity
NIVI Development P/S
Ørestads Boulevard 5
2300 København S
© NIVI Development